Scarica l'app Stockscreener
18.52
2.22%
-0.42
Dopo l'orario di chiusura:
19.45
0.93
+5.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Tandem Diabetes Care Q4 Earnings Call Highlights - Yahoo Finance
Tandem Diabetes Care Q4 2025 Financial Report & Revenue Growth | 2026News and Statistics - IndexBox
Tandem Diabetes Care (TNDM) Surges 5% After Beating Q4 Expectati - GuruFocus
Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Strong Q4 Beat but Issues Cautious 2026 Sales Guidance - ChartMill
Tandem Diabetes Care (TNDM) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance Singapore
Tandem Diabetes's (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates - Finviz
Tandem Diabetes Care earnings beat by $0.08, revenue topped estimates - Investing.com Canada
Earnings Flash (TNDM) Tandem Diabetes Care Posts Q4 Loss $0.01, vs. FactSet Est of $0.07 Loss - marketscreener.com
Tandem Diabetes (TNDM) Surges 11% Following Positive Q4 Results and Outlook - GuruFocus
TNDM Surpasses Expectations with Strong Q4 Revenue - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates - TradingView
Earnings Flash (TNDM) Tandem Diabetes Care, Inc. Reports Q4 Revenue $290.4M, vs. FactSet Est of $277.0M - marketscreener.com
Insulin pump maker shifts to pay‑as‑you‑go after $1B sales year - Stock Titan
Tandem Diabetes faces earnings test as profitability questions loom By Investing.com - Investing.com Canada
Tandem Diabetes Care's Earnings Outlook - Benzinga
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - Yahoo Finance
Unlocking Q4 potential of Tandem Diabetes Care (TNDM): Exploring Wall Street estimates for key metrics - MSN
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring A 37.96% Potential Upside - DirectorsTalk Interviews
Unlocking Q4 Potential of Tandem Diabetes Care (TNDM): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Understanding Momentum Shifts in (TNDM) - Stock Traders Daily
Did t:slim X2 Legal Probe Just Shift Tandem Diabetes Care's (TNDM) Disclosure and Risk Narrative? - simplywall.st
Tandem Diabetes Care Announces Upcoming Conference PresentationsFebruary 12, 2026 - BioSpace
Tandem Diabetes Care (TNDM) to Release Earnings on Thursday - MarketBeat
Diabetes Care Devices Market to Reach USD 42.1 Billion by 2028, Growing at a 4.8% CAGR - industrytoday.co.uk
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Don't buy Tandem Diabetes Care until this big thing happens - MSN
Tandem Diabetes Care, Inc. (TNDM): Investor Outlook With A 38.40% Potential Upside - DirectorsTalk Interviews
Will Tandem Diabetes Care Inc. benefit from geopolitical trends2025 Key Highlights & Expert Verified Movement Alerts - mfd.ru
What’s the beta of Tandem Diabetes Care Inc. stockEarnings Summary Report & AI Enhanced Trading Signals - mfd.ru
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bluefield Daily Telegraph
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Avoiding Lag: Real-Time Signals in (TNDM) Movement - Stock Traders Daily
Abbott on track with dual sensor, FDA warns on FreeStyle Libre - Modern Healthcare
Artificial Pancreas System Market is expected to reach US$ - openPR.com
Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views - Benzinga
TNDM: Stifel Maintains Hold Rating, Raises PT to $20 | TNDM Stoc - GuruFocus
Stifel Nicolaus Issues Positive Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price - MarketBeat
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Momentum Shift - Sahm
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 29% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
United States Diabetes Devices Market to Reach US$ 19.44 Billion - openPR.com
Commit To Buy Tandem Diabetes Care At $13, Earn 14.2% Annualized Using Options - Nasdaq
Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? - Yahoo Finance
Investment Review: Will Tandem Diabetes Care Inc stock benefit from M AJuly 2025 Price Swings & Stepwise Trade Signal Guides - baoquankhu1.vn
Energy Moves: Is Tandem Diabetes Care Inc forming bullish engulfing patternsWeekly Stock Analysis & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Can Tandem Diabetes Care Inc. generate free cash flowJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Why Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Could Be Worth Watching - 富途牛牛
Tandem Diabetes Care Inc (TNDM) Stock Price Down 4.17% on Jan 28 - GuruFocus
Pleasing Signs As A Number Of Insiders Buy Tandem Diabetes Care Stock - Yahoo Finance
Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4 - Insider Monkey
Rosen Law Firm Investigates Tandem Diabetes Securities Claims - Intellectia AI
TNDM Stock: TD Cowen Boosts Price Target and Reaffirms Buy Ratin - GuruFocus
Can Tandem Diabetes Care Inc stock double in the next yearInsider Selling & Weekly Setup with ROI Potential - baoquankhu1.vn
A Look At Tandem Diabetes Care (TNDM) Valuation After Legal Probe Into t:slim X2 Pump Correction - Sahm
Discipline and Rules-Based Execution in TNDM Response - Stock Traders Daily
1.02%
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):